IA
BSX icon

IndexIQ Advisors’s Boston Scientific BSX Stock Holding History

IndexIQ Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$88K Buy
1,998
+408
+26% +$17.7K ﹤0.01% 1093
2021
Q4 		$68K Buy
1,590
+57
+4% +$2.4K ﹤0.01% 1112
2021
Q3 		$67K Sell
1,533
-19
-1% -$841 ﹤0.01% 1091
2021
Q2 		$66K Sell
1,552
-243
-14% -$10.2K ﹤0.01% 1083
2021
Q1 		$69K Buy
+1,795
New +$67.9K ﹤0.01% 1071
2020
Q4 		– Sell
-10,632
Closed -$406K – 1062
2020
Q3 		$406K Buy
10,632
+6,491
+157% +$250K 0.02% 316
2020
Q2 		$145K Buy
4,141
+3,656
+754% +$132K 0.01% 800
2020
Q1 		$16K Sell
485
-108,900
-100% -$4.25M ﹤0.01% 799
2019
Q4 		$4.95M Buy
109,385
+24,078
+28% +$1.01M 0.18% 104
2019
Q3 		$3.47M Sell
85,307
-29,177
-25% -$1.24M 0.12% 131
2019
Q2 		$4.92M Sell
114,484
-2,792
-2% -$107K 0.15% 94
2019
Q1 		$4.5M Buy
+117,276
New +$4.48M 0.13% 96

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

IndexIQ Advisors's BSX Position: Q1 2022 in Review

IndexIQ Advisors increased its Boston Scientific (BSX) stake by 26% in Q1 2022, buying an estimated $17.7K and bringing the position to 1,998 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #1093.

IndexIQ Advisors first reported a position in BSX in Q1 2019 and has held it in 12 quarters since. The position peaked at $4.95M in Q4 2019. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • IndexIQ Advisors held 1,998 shares of Boston Scientific worth $88K as of Q1 2022.
  • IndexIQ Advisors bought 408 Boston Scientific shares in Q1 2022, an estimated $17.7K.
  • Boston Scientific made up ﹤0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #1093 holding.
  • IndexIQ Advisors first reported a position in Boston Scientific in Q1 2019 and has held it in 12 quarters since.
  • IndexIQ Advisors's Boston Scientific position peaked at $4.95M in Q4 2019.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.